A subcutaneous polymeric opioid delivery system for the treatment of cancer pain

Stuart A. Grossman, Suzanne Nesbit

Research output: Contribution to journalArticlepeer-review

Abstract

The optimal control of pain related to cancer requires the use of potent opioid analgesics. Despite significant efforts by the World Health Organization and other international agencies, oral morphine and other opioids remain largely unavailable to 80% of the world's population. As more cancer cases are being diagnosed in the developing world than elsewhere, large numbers of patients worldwide suffer from cancer-related pain without reasonable therapeutic options. This manuscript describes a polymeric opioid delivery system designed to provide opioids subcutaneously at a continuous rate for 1-3. months alleviating concerns regarding compliance, misuse, diversion and costs. This approach to opioid administration could substantially impact the global treatment of patients with cancer pain.

Original languageEnglish (US)
Pages (from-to)257-259
Number of pages3
JournalEuropean Journal of Pain Supplements
Volume4
Issue number4
DOIs
StatePublished - Nov 1 2010

Keywords

  • Cancer pain
  • Developing nations
  • Hydromorphone
  • Implant
  • Opioids
  • Polymer
  • Subcutaneous

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine

Fingerprint Dive into the research topics of 'A subcutaneous polymeric opioid delivery system for the treatment of cancer pain'. Together they form a unique fingerprint.

Cite this